Determination of the Glycemic Index of Products Varying in Levels of Refined and Whole Grain Corn

Exclusion Criteria

• •Self-reported pregnant or breastfeeding women.
• •Known history of gastrointestinal disease (e.g., diverticulitis, Crohns disease, coeliac disease etc.), bariatric surgery, AIDS, hepatitis, a history or presence of clinically important endocrine (including Type 1 or Type 2 diabetes mellitus), or any condition which might, in the opinion of the medical director either: 1) make participation dangerous to the participant or to others, or 2) affect the results.
• •Use of medications known to influence carbohydrate metabolism, gastrointestinal function or appetite, including, but not limited to adrenergic blockers, diuretics, thiazolidinediones, metformin and systemic corticosteroids within 4 weeks of the screening visit, or any medication which might, in the opinion of the medical director either: 1) make participation dangerous to the participant or to others, or 2) affect the results.
• •Major trauma or surgical event within 3 months of screening.
• •Unwillingness or inability to comply with the experimental procedures and to follow INQUIS health and safety policies.
• •Known intolerance, sensitivity or allergy to test products.
• •Participation in any clinical trial within the past 30 days (with the exception of routine GI testing of commonly consumed foods) or any PepsiCo sponsored trial within the past 3 months.